Some improvement. There is an improvement overall I believe. It would have been nice to see larger revenue due to products, but the fact of the matter is, revenue often comes from a blend of directions and preceeding time-frames. Sounds like future revenues from China could come in a similar fashion. 2013 could potentially see a large rise in share price. Who knows how large the Chinese order is and how far along they are in the Latin American markets. Potentially huge. I also think they could be buttoning up contracts in North America, Asia and Africa as well. Patience will pay off. Good luck to all of us patient holders.